Skip to main content
SpringerLink
Log in

ADRs with bivalirudin as anticoagulant during PCI

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Li P, et al. Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study Frontiers in Cardiovascular Medicine : 17 May 2022. Available from: URL: https://doi.org/10.3389/fcvm.2021.781632

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ADRs with bivalirudin as anticoagulant during PCI. Reactions Weekly 1907, 4 (2022). https://doi.org/10.1007/s40278-022-15263-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15263-1

Search

Navigation